first glp-1 approved for weight loss US approves pill loss: Novo Nordisk World Health Organization issues first-ever

Start low, monitor closely, and adjust: Change dose or switch medicine if side effects or inadequate response occur

The daily pill trades the convenience of once-weekly injection for the freedom of no needles, but adds dosing constraints (empty stomach, limited water, 30-minute food restriction)

Visible shifts in retail spaces: Larger retailers were making changes by replacing HFSS products with non-HFSS and non-food items in prominent areas

This data-driven approach bridges the gap between insurance limitations and personalized care, enabling faster access to treatment that fits your unique needs

Heres what to know What kind of diet and exercise plan works best with semaglutide